ALLIANCEBERNSTEIN L.P. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$553,000
-12.1%
162,790
-2.7%
0.00%
Q2 2018$629,000
+0.3%
167,310
+9.1%
0.00%
Q1 2018$627,000
-2.3%
153,350
+11.0%
0.00%
Q4 2017$642,000
-57.5%
138,150
-35.0%
0.00%
-100.0%
Q3 2017$1,510,000
+8.9%
212,640
+11.0%
0.00%0.0%
Q2 2017$1,386,000
+63.4%
191,650
+39.2%
0.00%0.0%
Q1 2017$848,000
-3.1%
137,640
-7.8%
0.00%0.0%
Q4 2016$875,000
+10.3%
149,3400.0%0.00%0.0%
Q3 2016$793,000
-25.6%
149,340
-7.3%
0.00%0.0%
Q2 2016$1,066,000
+41.8%
161,0400.0%0.00%0.0%
Q1 2016$752,000
-15.7%
161,040
-8.8%
0.00%0.0%
Q4 2015$892,000
+43.6%
176,5400.0%0.00%0.0%
Q3 2015$621,000
-64.8%
176,540
-0.1%
0.00%0.0%
Q2 2015$1,763,000
-22.3%
176,700
-0.9%
0.00%
-50.0%
Q1 2015$2,270,000
-9.2%
178,300
+0.9%
0.00%0.0%
Q4 2014$2,500,000
-0.3%
176,700
-3.1%
0.00%0.0%
Q3 2014$2,507,000
-10.6%
182,3000.0%0.00%0.0%
Q2 2014$2,804,000
+8.6%
182,300
+20.3%
0.00%0.0%
Q1 2014$2,583,000
+31.4%
151,600
-0.2%
0.00%0.0%
Q4 2013$1,966,000
+29.9%
151,839
+1.4%
0.00%
+100.0%
Q3 2013$1,513,000
+35.2%
149,802
+0.0%
0.00%0.0%
Q2 2013$1,119,000149,8000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
VHCP Management, LLC 700,273$10,770,0005.76%
HARVEY CAPITAL MANAGEMENT INC 932,400$14,340,0005.13%
Camber Capital Management LP 3,000,000$46,140,0003.02%
Baupost Group 10,539,986$162,105,0002.64%
SECTORAL ASSET MANAGEMENT INC 3,741,656$57,547,0002.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,884,409$59,742,0002.40%
Knoll Capital Management, LLC 200,000$3,076,0001.37%
DAFNA Capital Management LLC 92,400$1,421,0001.35%
NORTHPOINTE CAPITAL LLC 892,011$13,719,0001.32%
Rhenman & Partners Asset Management AB 240,000$3,691,0001.10%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders